NCT06233201View on ClinicalTrials.gov

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

July 14, 2024

Study Completion Date

July 28, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Test product

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Manufactured by: Mankind Pharma Limited, India

DRUG

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Reference product

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Manufactured by: Patheon Puerto Rico, Puerto Rico 00674

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06233201 - Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator | Biotech Hunter | Biotech Hunter